Thind M, Miraglia E, Ling C, Khan M, Glembocki A, Bourdon C
Cell Rep. 2024; 43(8):114493.
PMID: 39028622
PMC: 11372442.
DOI: 10.1016/j.celrep.2024.114493.
Aryal S, Lu R
Adv Exp Med Biol. 2024; 1459:405-430.
PMID: 39017854
DOI: 10.1007/978-3-031-62731-6_18.
Slany R
Hemasphere. 2024; 8(6):e83.
PMID: 38836099
PMC: 11145742.
DOI: 10.1002/hem3.83.
Lambert M, Jambon S, Bouhlel M, Depauw S, Vrevin J, Blanck S
Hemasphere. 2024; 8(5):e77.
PMID: 38716146
PMC: 11072194.
DOI: 10.1002/hem3.77.
He L, Feng X, Hu C, Liu S, Sheng H, Cai B
BMC Genomics. 2024; 25(1):358.
PMID: 38605318
PMC: 11007997.
DOI: 10.1186/s12864-024-10231-3.
A C/ebpα isoform specific differentiation program in immortalized myelocytes.
Garcia-Cuellar M, Akan S, Slany R
Leukemia. 2023; 37(9):1850-1859.
PMID: 37532789
PMC: 10457184.
DOI: 10.1038/s41375-023-01989-8.
Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.
Feng A, He L, Jiang J, Chu Y, Zhang Z, Fang K
Cancer Sci. 2023; 114(8):3270-3286.
PMID: 37248653
PMC: 10394159.
DOI: 10.1111/cas.15842.
/-transgenic zebrafish develops acute myeloid leukaemia-like disease with rapid onset and high penetrance.
Wang W, Li H, Huang M, Wang X, Li W, Qian X
Open Biol. 2022; 12(10):220172.
PMID: 36285442
PMC: 9597180.
DOI: 10.1098/rsob.220172.
HOXA9 has the hallmarks of a biological switch with implications in blood cancers.
Talarmain L, Clarke M, Shorthouse D, Cabrera-Cosme L, Kent D, Fisher J
Nat Commun. 2022; 13(1):5829.
PMID: 36192425
PMC: 9530117.
DOI: 10.1038/s41467-022-33189-w.
HOXA9/MEIS1 targets in leukemia: reinforced signaling networks and therapeutic opportunities.
Zhou X, Lu R
Haematologica. 2022; 108(5):1205-1207.
PMID: 36005566
PMC: 10153530.
DOI: 10.3324/haematol.2022.281779.
Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia.
Sahoo B, Lin Y, Tu C, Lin C, Liao W, Li F
Haematologica. 2022; 108(5):1284-1299.
PMID: 36005562
PMC: 10153537.
DOI: 10.3324/haematol.2022.281151.
Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc.
Garcia-Cuellar M, Prinz A, Slany R
Haematologica. 2022; 107(11):2601-2616.
PMID: 35546301
PMC: 9614532.
DOI: 10.3324/haematol.2022.280831.
SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia.
Polyanskaya S, Moreno R, Lu B, Feng R, Yao Y, Irani S
Cell Rep. 2022; 38(2):110233.
PMID: 35021089
PMC: 8796272.
DOI: 10.1016/j.celrep.2021.110233.
Identification of RIOK2 as a master regulator of human blood cell development.
Ghosh S, Raundhal M, Myers S, Carr S, Chen X, Petsko G
Nat Immunol. 2021; 23(1):109-121.
PMID: 34937919
DOI: 10.1038/s41590-021-01079-w.
Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia.
Zhao L, Zhang P, Galbo P, Zhou X, Aryal S, Qiu S
Blood Adv. 2021; 5(22):4727-4740.
PMID: 34597364
PMC: 8759131.
DOI: 10.1182/bloodadvances.2021004469.
Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein.
Bon C, Si Y, Pernak M, Barbachowska M, Levi-Acobas E, Cadet Daniel V
Molecules. 2021; 26(17).
PMID: 34500733
PMC: 8434109.
DOI: 10.3390/molecules26175300.
HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways.
Miyamoto R, Kanai A, Okuda H, Komata Y, Takahashi S, Matsui H
Elife. 2021; 10.
PMID: 34310280
PMC: 8313233.
DOI: 10.7554/eLife.64148.
Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
Riedel S, Lu C, Xie H, Nestler K, Vermunt M, Lenard A
Mol Cell. 2021; 81(11):2332-2348.e9.
PMID: 33974912
PMC: 8380056.
DOI: 10.1016/j.molcel.2021.04.014.
Menin is necessary for long term maintenance of meningioma-1 driven leukemia.
Libbrecht C, Xie H, Kingsley M, Haladyna J, Riedel S, Alikarami F
Leukemia. 2021; 35(5):1405-1417.
PMID: 33542482
PMC: 8102197.
DOI: 10.1038/s41375-021-01146-z.
Overexpression of HOXA9 upregulates NF-κB signaling to promote human hematopoiesis and alter the hematopoietic differentiation potentials.
Zeng J, Yi D, Sun W, Liu Y, Chang J, Zhu L
Cell Regen. 2021; 10(1):9.
PMID: 33426581
PMC: 7797385.
DOI: 10.1186/s13619-020-00066-0.